ZOTA1,095.00

Zota Health Care LImited

· Unclassified
₹ CrorePeersMARINEBETATHEJOMcap ₹3,792 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.890.980.930.94
Interest Burden (Pretax/EBIT) ×1.291.181.251.19
EBIT Margin %-6.94-16.70-11.87-15.20
Asset Turnover ×0.790.670.480.48
Financial Leverage (Assets/Equity) ×2.541.931.621.62
ROE (5-step product) %-15.94-25.08-10.72-13.36
ROE (reported, avg-equity basis) %-15.95-24.83-10.62-10.62
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.